Dai Chung

Vanderbilt investigators have discovered that a sirtuin protein has oncogenic properties in neuroblastoma cells — and that blocking it reduces their growth and tumor-like characteristics. Read More

A compound identified at Vanderbilt represents a new lead for treating rare, aggressive childhood cancers called Ewing sarcomas. Read More

Macie Glover sprinted across the gym floor at school earlier this year, tripped and crashed into a wall. In a bizzare sequence of events, she hit her head and arm and scraped her knees as the force of the crash propelled her whole body arching backward into a crescent shape. Read More

An inhibitor of cell metabolism may be a good therapeutic target for neuroblastoma, which accounts for about 15 percent of pediatric cancer-related deaths. Read More

The American College of Surgeons (ACS) Committee on Trauma has verified Monroe Carell Jr. Children’s Hospital at Vanderbilt as a Level I pediatric trauma center, recognizing the hospital’s commitment to provide the highest level of care for injured pediatric patients. Read More

The sphere-forming frequency of neuroblastoma cells is a measure of their proliferative capacity and could help guide treatment strategies for neuroblastoma. Read More

When Kendra Kaufman walked into to a recent follow-up appointment with surgeon Dai Chung, M.D., the only help she needed to steady her steps came from ankle-foot-orthotics. Read More

Golf ball-sized gallstones camped out in Joseph Gray’s gallbladder had been causing him stomach discomfort for months. Read More

The Rally Foundation awarded an $80,000 grant to the Monroe Carell Jr. Children’s Hospital at Vanderbilt to fund a research study on the treatment of neuroblastoma. Read More

Ten Vanderbilt University faculty members who have been named to new endowed chairs were recognized for their remarkable achievements and contributions on Feb. 28. Read More